Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 69

Cited In for PubMed (Select 19380405)

1.

Response evaluation after primary systemic therapy of Her2 positive breast cancer - an observational cross-sectional study.

Tőkés T, Szentmártoni G, Torgyík L, Kajáry K, Lengyel Z, Györke T, Molnár BA, Tőkés AM, Kulka J, Dank M.

Croat Med J. 2015 Apr 20;56(2):128-38.

2.

Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study.

Bowen SR, Nyflot MJ, Herrmann C, Groh CM, Meyer J, Wollenweber SD, Stearns CW, Kinahan PE, Sandison GA.

Phys Med Biol. 2015 May 7;60(9):3731-46. doi: 10.1088/0031-9155/60/9/3731. Epub 2015 Apr 17.

PMID:
25884892
3.

Intra-individual comparison of PET/CT with different body weight-adapted FDG dosage regimens.

Geismar JH, Stolzmann P, Sah BR, Burger IA, Seifert B, Delso G, von Schulthess GK, Veit-Haibach P, Husmann L.

Acta Radiol Open. 2015 Jan 29;4(2):2047981614560076. doi: 10.1177/2047981614560076. eCollection 2015 Feb.

4.

Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.

Nozawa A, Rivandi AH, Kanematsu M, Hoshi H, Piccioni D, Kesari S, Hoh CK.

Nucl Med Commun. 2015 Jun;36(6):573-81. doi: 10.1097/MNM.0000000000000288.

5.

The independent functioning of the orchidopexied congenital undescended testis as assessed by positron emission tomography/computed tomography.

Meij-de Vries A, Lazarenko SV, Knol RJ, Meijer RW, van der Plas EM, Heij HA.

World J Nucl Med. 2015 Jan-Apr;14(1):31-5. doi: 10.4103/1450-1147.150531.

6.

FDG-PET Response Prediction in Pediatric Hodgkin's Lymphoma: Impact of Metabolically Defined Tumor Volumes and Individualized SUV Measurements on the Positive Predictive Value.

Hussien AE, Furth C, Schönberger S, Hundsdoerfer P, Steffen IG, Amthauer H, Müller HW, Hautzel H.

Cancers (Basel). 2015 Jan 28;7(1):287-304. doi: 10.3390/cancers7010287.

7.

Insight on automated lesion delineation methods for PET data.

Firouzian A, Kelly MD, Declerck JM.

EJNMMI Res. 2014 Dec 14;4:69. doi: 10.1186/s13550-014-0069-8. eCollection 2014.

8.

Positron emission tomography to assess hypoxia and perfusion in lung cancer.

Verwer EE, Boellaard R, van der Veldt AA.

World J Clin Oncol. 2014 Dec 10;5(5):824-44. doi: 10.5306/wjco.v5.i5.824. Review.

9.

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ.

Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54. doi: 10.1007/s00259-014-2961-x. Epub 2014 Dec 2.

10.

Role of PET quantitation in the monitoring of cancer response to treatment: Review of approaches and human clinical trials.

Doot RK, McDonald ES, Mankoff DA.

Clin Transl Imaging. 2014 Aug 1;2(4):295-303.

PMID:
25229053
11.

Uptake of (18)F-fluoro-2-deoxyglucose in the Healthy Testes of Young Men as Assessed by Positron Emission Tomography/Computed Tomography; Including the Inter- and Intra-observer Variation.

Meij-de Vries A, Knol RJ, Lazarenko SV, Meijer RW, van der Plas EM, Heij HA.

World J Nucl Med. 2014 May;13(2):88-93. doi: 10.4103/1450-1147.139137.

12.

The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases.

Nielsen K, Scheffer HJ, Pieters IC, van Tilborg AA, van Waesberghe JH, Oprea-Lager DE, Meijerink MR, Kazemier G, Hoekstra OS, Schreurs HW, Sietses C, Meijer S, Comans EF, van den Tol PM.

BMC Med Imaging. 2014 Aug 8;14:27. doi: 10.1186/1471-2342-14-27.

13.

What parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions?

Kunikowska J, Matyskiel R, Toutounchi S, Grabowska-Derlatka L, Koperski L, Królicki L.

Eur J Nucl Med Mol Imaging. 2014 Dec;41(12):2273-80. doi: 10.1007/s00259-014-2844-1. Epub 2014 Jul 16.

14.

Computer-assisted delineation of lung tumor regions in treatment planning CT images with PET/CT image sets based on an optimum contour selection method.

Jin Z, Arimura H, Shioyama Y, Nakamura K, Kuwazuru J, Magome T, Yabu-Uchi H, Honda H, Hirata H, Sasaki M.

J Radiat Res. 2014 Nov;55(6):1153-62. doi: 10.1093/jrr/rru056. Epub 2014 Jun 30.

15.

Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers.

Siddiqui F, Yao M.

World J Radiol. 2014 Jun 28;6(6):238-51. doi: 10.4329/wjr.v6.i6.238. Review.

16.

Evaluation of Dixon Sequence on Hybrid PET/MR Compared with Contrast-Enhanced PET/CT for PET-Positive Lesions.

Jeong JH, Cho IH, Kong EJ, Chun KA.

Nucl Med Mol Imaging. 2014 Mar;48(1):26-32. doi: 10.1007/s13139-013-0240-6. Epub 2013 Oct 15.

17.

Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.

Rahim MK, Kim SE, So H, Kim HJ, Cheon GJ, Lee ES, Kang KW, Lee DS.

Nucl Med Mol Imaging. 2014 Mar;48(1):1-15. doi: 10.1007/s13139-013-0260-2. Epub 2014 Jan 22. Review.

18.

Comparison of SUVs Normalized by Lean Body Mass Determined by CT with Those Normalized by Lean Body Mass Estimated by Predictive Equations in Normal Tissues.

Kim WH, Kim CG, Kim DW.

Nucl Med Mol Imaging. 2012 Sep;46(3):182-8. doi: 10.1007/s13139-012-0146-8. Epub 2012 Jun 21.

19.

A review on segmentation of positron emission tomography images.

Foster B, Bagci U, Mansoor A, Xu Z, Mollura DJ.

Comput Biol Med. 2014 Jul;50:76-96. doi: 10.1016/j.compbiomed.2014.04.014. Epub 2014 Apr 28. Review.

PMID:
24845019
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk